Hyperkalemia diagnosed by implantable cardioverter defibrillator T wave sensing

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 5, 2001, Pages 908-909

  Arthur, Wayne ^a,b   Kaye, G C ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

^b PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

Author keywords

Hyperkalemia; Implantable cardioverter defibrillator; Pacemaker dependence

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; CASE REPORT; CATHETER ABLATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; ELECTROCARDIOGRAM; HUMAN; HYPERKALEMIA; IMPLANT; MALE; PACEMAKER; T WAVE;

EID: 0035002070     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.00908.x     Document Type: Article

References (2)

1. 1. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341:709-717.
2. 2. Dohrmann ML, Goldschiager NF. Myocardial stimulation threshold in patients with cardiac pacemakers: Effect of physiologic variables, pharmacologic agents, and lead electrodes. Cardiol Clin 1985; 3:527-537.